MeiraGTx Holdings (MGTX) Equity Average (2018 - 2025)
MeiraGTx Holdings (MGTX) reported Equity Average of -$23.2 million for Q4 2025, down 128.34% on a YoY basis from $81.8 million in Q4 2024, and down 23.28% quarter-over-quarter from -$18.8 million in Q3 2025.
MeiraGTx Holdings (MGTX) Equity Average (2018 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Equity Average for 8 years, with the latest figure at -$23.2 million in Q4 2025.
- For the quarter ending Q4 2025, Equity Average fell 128.34% year-over-year to -$23.2 million; the trailing twelve-month figure through Dec 2025 stood at -$23.2 million (down 128.34% YoY), and the FY2025 full-year result was $31.0 million, down 69.89% from the prior year.
- Equity Average for Q4 2025 stood at -$23.2 million, down from -$18.8 million in the prior quarter.
- The five-year high for Equity Average was $229.7 million in Q1 2021, with the low at -$23.2 million in Q4 2025.
- Historically, Equity Average has averaged $113.2 million across 5 years, with a median of $111.4 million in 2023.
- Annual changes were most pronounced in 2024 — Equity Average increased 24.98% — and 2025, when it plunged 128.34%.
- MeiraGTx Holdings' Equity Average stood at $186.6 million in 2021, then tumbled by 35.59% to $120.2 million in 2022, then fell by 4.3% to $115.0 million in 2023, then decreased by 28.91% to $81.8 million in 2024, then tumbled by 128.34% to -$23.2 million in 2025.
- The last three Equity Average figures came in at -$23.2 million (Q4 2025), -$18.8 million (Q3 2025), and $18.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | -23.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -23.18 Mn |
| Sep 30, 2025 | -18.80 Mn |
| Jun 30, 2025 | 18.03 Mn |
| Mar 31, 2025 | 50.46 Mn |
| Dec 31, 2024 | 81.78 Mn |
| Sep 30, 2024 | 87.89 Mn |
| Jun 30, 2024 | 100.89 Mn |
| Mar 31, 2024 | 129.96 Mn |
| Dec 31, 2023 | 115.03 Mn |
| Sep 30, 2023 | 107.71 Mn |
| Jun 30, 2023 | 106.87 Mn |
| Mar 31, 2023 | 103.98 Mn |
| Dec 31, 2022 | 120.20 Mn |
| Sep 30, 2022 | 132.32 Mn |
| Jun 30, 2022 | 151.63 Mn |
| Mar 31, 2022 | 173.34 Mn |
| Dec 31, 2021 | 186.62 Mn |
| Sep 30, 2021 | 196.78 Mn |
| Jun 30, 2021 | 213.26 Mn |
| Mar 31, 2021 | 229.68 Mn |